Down-regulation of pro-inflammatory response genes of circulating leukocytes in ICU patients with severe pneumonia meeting criteria of systemic inflammatory response syndrome (SIRS) Source: Eur Respir J 2003; 22: Suppl. 45, 543s Year: 2003
Effect of corticosteroids on inflammatory markers in patients with severe cap and high inflammatory response according to presence of lymphopenia Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment Year: 2019
Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007
Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008
Cytokine regulation of local and systemic inflammation in COPD patients Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010
Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003
Community-aquired pneumonia: systemic and local inflammatory response in treatment failure Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008
Markers of pulmonary injury and inflammation are elevated in the serum of patients with chronic cough Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Systemic inflammation and systemic oxidative stress in acute COPD exacerbation Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010
Serum TNFα and IL8 as markers of systemic inflammation in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005
Systemic inflammatory response in relation to disease severity and nutritional depletion in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 31s Year: 2004
Polymorphisms of innate immune response genes and severe systemic inflammatory response syndromes Source: Eur Respir J 2006; 28: Suppl. 50, 347s Year: 2006
The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010
COPD: inflammatory mechanisms and systemic consequences Source: Eur Respir Mon 2013; 59: 13-27 Year: 2013
Expression of CD282+/CD284+ on blood granulocytes and its relationship to cytokine status in patients with stable chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021
Serum immunoglobulin level is a useful marker for the risk of opportunistic infection in steroid dependent patients with chronic inflammatory airway diseases Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Pattern of bronchial colonization and inflammatory response in patients with bronchiectasis and immunoglobulin deficiency (Igdef) Source: Eur Respir J 2001; 18: Suppl. 33, 466s Year: 2001
High mobility group box protein 1 (HMGB1) production in highly vascularized alveolar lesions causes acute exacerbation in idiopathic pulmonary fibrosis Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005
Dysregulation of systemic and local immune response in cystic fibrosis patients with chronic P. aeruginosa infection Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004